About this trial
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.
Eligibility criteria
Qualifiers
Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disorders
Patients with diagnosis of Parkinson's Disease
Diagnosis of Parkinson's Disease according to the United Kingdom (UK) Parkinson's Disease Society Brain Bank
Diagnosis of Movement Disorder not related to Parkinson's Disease
Disqualifiers
There are no restrictions for participation in the study based on age, severity of illness or presence of cognitive impairment, as long as the person is able to complete the research assessments.
Trial design
Treatments tested in this trial
- Observation
Treatment groups
Sponsors and collaborators
Casa di Cura San Raffaele Cassino
Lead sponsor
IRCCS San Raffaele Roma
Collaborator
San Raffaele Telematic University
Collaborator
University of Urbino "Carlo Bo"
Collaborator
University of Cassino and Southern Lazio
Collaborator
University of Roma La Sapienza
Collaborator
Politecnico di Milano
Collaborator